Tag: Diabetes
Eli Lilly’s diabetic drug Mounjaro marks full year in market with US$5B in sales
by Editor | Feb 7, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Mounjaro a diabetic drug by Eli Lilly, an American pharmaceutical company...
Read MoreAbu Dhabi’s ADSCC, Kyoto University, Rege Nephro ink new pact for diabetes care
by Editor | Jan 18, 2024 | AFRICAN & MIDDLE EAST NEWS, LATEST NEWS, Medical Devices & Innovations, Science, Technology & Research | 0
UAE – Abu Dhabi Stem Cells Center (ADSCC), Kyoto University – Center for iPS Cell Research...
Read MoreNovo Nordisk completes COMBINE 3 phase 3a trial on Type 2 Diabetes
by Editor | Jan 9, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing, Science, Technology & Research, WORLD NEWS | 0
DENMARK – Novo Nordisk has completed its COMBINE 3 phase 3a trial of once-weekly IcoSema, a...
Read MorePfizer halts twice-daily Danuglipron study due to side effects, shifts focus to once-daily version
by Editor | Dec 1, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Pharmaceutical giant Pfizer has abandoned the development of the twice-daily version of its...
Read MoreAbbott unveils its FreeStyle LibreLink mobile app for Indian users
by Editor | Nov 22, 2023 | LATEST NEWS, Medical Devices & Innovations, WORLD NEWS | 0
INDIA – Abbott has rolled out the FreeStyle LibreLink app designed specifically for Indian users...
Read MoreKenya’s fight against diabetes and hypertension gets a boost with new four-year project
by Editor | Nov 16, 2023 | AFRICAN & MIDDLE EAST NEWS, Government, Regulatory & Policy News, LATEST NEWS | 0
KENYA— The Kenyan Ministry of Health (MoH) has unveiled the ‘Integrating Diabetes and...
Read MoreBelgium contemplates temporarily banning Novo Nordisk’s Ozempic
by Editor | Nov 15, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
BELGIUM — Belgium is deliberating on a temporary ban on Novo Nordisk’s diabetes treatment,...
Read MoreNovo Nordisk phases out Levemir in the U.S. amidst growing insulin pricing pressure
by Editor | Nov 10, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Novo Nordisk, a major player in the pharmaceutical industry, has announced plans to...
Read MoreFDA greenlights Eli Lilly’s Zepbound: A game-changer in weight loss medication landscape
by Editor | Nov 9, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — The Food and Drug Administration (FDA) has granted approval to Eli Lilly’s Zepbound, a...
Read MoreNovo Nordisk expands innovative approaches to tackle obesity and Type 2 diabetes
by Editor | Nov 7, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
DENMARK — Novo Nordisk, renowned for its successful pharmaceuticals like Ozempic, Wegovy, Victoza,...
Read MoreEli Lilly resolves Mounjaro supply issues, continues expansion amid surging demand
by Editor | Nov 5, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Eli Lilly has reported improvements in the supply of its popular diabetes drug, Mounjaro, in...
Read MoreGlenmark Pharmaceuticals introduces innovative triple-drug combination for type 2 diabetes
by Editor | Oct 24, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA — Glenmark Pharmaceuticals has launched a triple-drug fixed-dose combination (FDC) in India,...
Read More